LUPINI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 4.543
AS - Asia 2.292
EU - Europa 1.712
SA - Sud America 301
AF - Africa 50
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.903
Nazione #
US - Stati Uniti d'America 4.431
SG - Singapore 869
CN - Cina 557
IT - Italia 351
DE - Germania 294
VN - Vietnam 280
PL - Polonia 273
BR - Brasile 225
FI - Finlandia 189
HK - Hong Kong 171
GB - Regno Unito 154
TR - Turchia 132
UA - Ucraina 103
SE - Svezia 67
FR - Francia 62
CA - Canada 57
IN - India 53
JP - Giappone 49
ID - Indonesia 43
MX - Messico 43
RU - Federazione Russa 43
BD - Bangladesh 31
BE - Belgio 31
NL - Olanda 30
AR - Argentina 27
RO - Romania 21
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
IQ - Iraq 18
AT - Austria 16
ES - Italia 15
LT - Lituania 12
PK - Pakistan 12
CO - Colombia 11
CL - Cile 9
IE - Irlanda 9
TN - Tunisia 9
EC - Ecuador 8
EG - Egitto 7
IR - Iran 7
PH - Filippine 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
MY - Malesia 6
PE - Perù 6
BO - Bolivia 5
DZ - Algeria 5
KZ - Kazakistan 5
OM - Oman 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
JO - Giordania 4
NP - Nepal 4
AU - Australia 3
GR - Grecia 3
KE - Kenya 3
LV - Lettonia 3
MA - Marocco 3
TW - Taiwan 3
BH - Bahrain 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IL - Israele 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PY - Paraguay 2
QA - Qatar 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
MT - Malta 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TL - Timor Orientale 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.903
Città #
Ashburn 586
Singapore 517
Fairfield 430
Woodbridge 349
San Jose 291
Warsaw 271
Houston 228
Ann Arbor 223
Beijing 210
Chandler 203
Santa Clara 177
Seattle 177
Munich 171
Hong Kong 170
Cambridge 135
Wilmington 128
Jacksonville 126
Ferrara 114
Helsinki 113
Dallas 105
New York 105
Ho Chi Minh City 94
Los Angeles 72
Izmir 66
Hanoi 53
Milan 52
Tokyo 49
Turku 47
Shanghai 46
Nanjing 45
Princeton 37
Council Bluffs 36
Jakarta 36
Lauterbourg 34
Orem 33
Brussels 31
London 28
Mexico City 27
San Diego 27
Boardman 23
Buffalo 23
Tianjin 23
São Paulo 22
Chicago 21
Nanchang 21
Atlanta 19
Bremen 19
Montreal 18
Phoenix 18
Addison 17
Da Nang 17
Denver 17
Timisoara 17
Falls Church 16
Rome 16
Toronto 16
Amsterdam 14
Brooklyn 14
Chennai 14
Johannesburg 14
Brno 13
Dong Ket 13
Shenyang 13
The Dalles 13
Changsha 12
Haiphong 12
Nuremberg 12
Manchester 11
Stockholm 11
Bologna 10
Boston 10
Poplar 10
Redwood City 10
Rio de Janeiro 10
Dearborn 9
Dublin 9
Hebei 9
Moscow 9
Barnet 8
Columbus 8
Frankfurt am Main 8
Kunming 8
San Francisco 8
Charlotte 7
Santiago 7
Washington 7
Ankara 6
Auburn Hills 6
Baghdad 6
Belo Horizonte 6
Falkenstein 6
Hefei 6
Jiaxing 6
Mountain View 6
Naples 6
Salt Lake City 6
Vienna 6
Biên Hòa 5
Brasília 5
Des Moines 5
Totale 6.359
Nome #
Absolute quantification of cell-free microRNAs in cancer patients 328
In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI 312
A microRNA signature to predict risk progression of vulvar lichen sclerosus to squamous cell carcinoma 301
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 298
High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy 291
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 283
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 269
Ruolo del miR-221 nella tumorigenesi epatica 269
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations. 264
An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness 259
Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: Clinical and biological correlations 254
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics 247
Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25 242
Circulating non-coding RNA as biomarkers in colorectal cancer 237
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 236
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 233
HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights 226
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia: Clinical and biologic correlations 219
Circulating microRNA quantification using DNA-binding dye chemistry and droplet digital PCR 218
Erratum to: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations (J Hematol Oncol. (2016) 9 (88) DOI:10.1186/s13045-016-0320-z) 215
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 212
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 208
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 206
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 204
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy 204
Estrogen receptor mutation: a new strategy to overcome endocrine resistance 187
Mutated beta-catenin evades a microRNA-dependent regulatory loop 183
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 182
Molecular biomarkers predicting early development of endometrial carcinoma: A pilot study 179
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer 171
Inhibiting the oncogenic mir-221 by microRNA sponge: Toward microRNA-based therapeutics for hepatocellular carcinoma 170
Oncogenic role of miR-483-3p at the IGF2/483 locus 168
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 168
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 166
Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients 166
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 162
The importance of microRNAs in RAS oncogenic activation in human cancer 151
Microbiota and environmental health monitoring of mouse colonies by metagenomic shotgun sequencing 128
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 124
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy 119
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 118
null 89
null 77
null 63
Totale 9.006
Categoria #
all - tutte 37.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.614
Totale 38.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021302 0 0 0 0 0 0 0 0 0 147 87 68
2021/2022451 23 30 30 23 23 23 45 24 16 33 53 128
2022/2023474 48 41 29 67 66 72 35 31 52 2 17 14
2023/2024332 28 36 11 5 31 85 16 28 7 8 5 72
2024/20251.520 35 35 95 78 147 171 93 69 309 114 183 191
2025/20263.321 389 135 267 394 502 242 488 220 386 298 0 0
Totale 9.006